Icon
+91 94997 68112
Login Register

Synjardy XR - (5,10,12.5,25 mg/1 gm, Tablet, Extended Release)

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Boehringer Ingelheim
5,10,12.5,25 mg/1 gm, Tablet, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Yes
*****, *** **** *** ********* *** ****. **** ***** * **** ** *** **** ************ *********. ** ****** **** *** **** **** ****** ** *** ****. ***** ***** ***** * **** ** ** '*** *** '*** ******* *** *** *********. ** ****** **** *** ***** **** ****** ** ***** ****. ***** ******** ********* ******** ** *** *** ****. ****** ******** *** ****** ** *** **, **** *** **** ****** ** ***** **, ****.
Synjardy XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
***** (*******) ******* *** ********* *** ********* *** ********* ******* *** ********* *** *********
*** **** ******* *** ********* *** ********* *** ********* ******* *** ********* *** *********
********* ******* *** ********* *** ********* ********* *** ********* ******* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** (*******) *** \ ********* *** **, **** ******* **** ******* *** **** *** *** ****
*** **** *** \ ********* *** **, **** ******* ********* ******** ******* *** **** *** *** ****
********* *** \ ********* *** *, **** ******* **** ******* *** **** *** *** ****
  1. *** **, **** : ********* ******** ********** ***** **'* **** ** ************* ** ******* '*** *** '***
  2. *** *, **** : ***** ****** ********** ***** *** **** ** ************* **** ****** ******* (**** ** ****)
  3. *** *, **** : *** **** ****** ********** ***** *** **** ** ************* **** ****** ******* (**** ** ****)
  4. *** *, **** : ********** ***** * **** ******* ********* ** ******* '*** *** '***
  5. *** **, **** : ********** **** * **** ******* ***** *** *** **** **** ****** ******* (**** ** ****)
  6. *** *, **** : ********** **** * **** ******* ***** ** ****** ******** (***** *, ****)
  7. *** **, **** : ***** ****** ********** ***** *** **** ** ************* **** ******* ******* (**** ** ****) *** ******** (***** *, ****)
  8. *** *, **** : ********** ***** * **** ******* ********* *** *** **** ** ****** ******** (***** *, ****)
  9. *** *, **** : ********** ***** * **** ******* ***** ** ******* ******* (**** ** ****) *** ******** (***** *, ****)
  10. *** *, **** : ***** ********* ******** *****://***.*****.***/*********/*****-********-*********-********-***-*************-***-*********-*************-**-*******/
  11. *** *, **** : *** ****** ******** ********** ***** *** **** ** ****** *** * ******
  12. *** *, **** : ********** **** *** ****** **** ****** '***, '***, '***, *** '***.
  13. *** **, **** : ****** ******** *** ****** ******** ** ***** **, ****.
  14. *** **, **** : ********** ******* **** *** **** ** *********** *****.
  15. *** **, **** : ********** **** *********, ***** *** *** ****** ** * ***** ****** ****** '*** (******** ** ***** **,****)
  16. *** **, **** : ********** *** ********* ******* ********** ** ******* *****.
  17. *** *, **** : ********** *** ***** (*******) ******* ********** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.